Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06408441
Recruiting
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Not applicable · Austria, Germany, Denmark, Spain, France, United Kingdom, Italy, Poland, Portugal, Sweden · 22 sites
Registry update: 3 Apr 2026
NCT06022159
Recruiting
A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.
Phase 2 · France · 11 sites
Registry update: 2 Jun 2026
NCT06073067
Recruiting
GRID Therapy for Extremity Soft Tissue Sarcoma
Not applicable · United States · 1 site
Registry update: 3 Sept 2026
NCT06129903
Recruiting
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Not applicable · United States · 8 sites
Registry update: 15 May 2026
NCT05400603
Recruiting
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Phase 1 · United States · 1 site
Registry update: 26 Dec 2025
NCT06156410
Recruiting
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Phase 1 · United States · 4 sites
Registry update: 3 Sept 2026
NCT05968768
Recruiting
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Phase 2 · Poland · 2 sites
Registry update: 7 Oct 2026
NCT05542407
Recruiting
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Phase 1 · United States · 1 site
Registry update: 29 Jan 2026
NCT06087861
Recruiting
5-Day Preoperative Radiation for Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 10 Jun 2026
NCT06103669
Recruiting
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
Not applicable · United States · 1 site
Registry update: 8 Jul 2026
2024-514441-11-00
Recruiting
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.
Phase 2 · Poland · 2 sites
Registry update: 6 Aug 2024
NCT05969860
Recruiting
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · United States · 2 sites
Registry update: 6 Nov 2026
NCT06094101
Recruiting
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
Phase 1/2 · Germany · 7 sites
Registry update: 4 May 2026
NCT06029218
Recruiting
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Not applicable · France · 1 site
Registry update: 25 Sept 2024
NCT05642455
Recruiting
SPEARHEAD-3 Pediatric Study
Phase 1/2 · United States · 10 sites
Registry update: 11 Aug 2026
NCT06021626
Recruiting
A Study of CRD3874-SI in People With Solid Tumors
Phase 1 · United States · 7 sites
Registry update: 21 Sept 2026
NCT07642375
Recruiting
Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients
Not applicable · Greece · 11 sites
Registry update: 11 Jun 2026
NCT05944913
Recruiting
Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy
Not applicable · France · 15 sites
Registry update: 8 Aug 2025
NCT05944237
Recruiting
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2 · United Kingdom · 6 sites
Registry update: 1 Oct 2026
NCT05985161
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Phase 2 · United States · 16 sites
Registry update: 23 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.